Investors

Investors

Our Vision

Driving impactful health improvements as a global leader in innovative and cost-effective rapid, near patient diagnostic test solutions.


Lumos Diagnostics FY21 Full Year Results
August 30, 2021

Lumos Diagnostics Holdings Limited (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced its full year results including Appendix 4E and Annual Report to Shareholders for the fiscal year ending on 30 June 2021. MORE


FY21 RESULTS BRIEFING
LETTER FROM OUR BOARD CHAIR AND CEO
FY21 ANNUAL REPORT
Further Information
If you have any questions, you should seek advice from your stockbroker, accountant, or other independent professional adviser, or call the Lumos Offer Information Line during business hours (AEST).
Australia: 1300 040 690
Outside Australia: +61 3 9415 4100

Investor-related questions? Get in touch!